On January 9, Globus Medical (GMED) was trading at a stock price of $43.79, which is an ~9.91% rise from its closing price of $39.84 on January 8. On January 4, Globus Medical’s stock price rose ~5.04% to $40.00 from its close of $38.08 on January 3. On January 3, the company hit its 52-week low of $38.01.
Futures for Canada's main stock index advanced on Friday, tracking a surge in commodity prices, while investors awaited an employment reading for more clues on the monetary policy path of the country's central bank. Spot gold prices rose over 1% and were on track for their best week since early April, while nonferrous metals, including copper also advanced, fuelled by risk-on sentiment and short-covering. Meanwhile, data on Thursday showed that the number of Americans filing new claims for unemployment benefits increased more than expected in last week, uplifting investor sentiment around interest rate cuts in the year.
Forestry and Land Scotland says hundreds of hectares have been restored at a number of locations.
If you're new to the WNBA and want to watch Caitlin Clark's rookie season, we've got you covered.
Christian Magoon, CEO of Amplify ETFs, entered the ETF marketplace in 2005. He knew at once he had to innovate with the best ETFs.
In April, the market sent a reminder message to investors in the best mutual funds and ETFs: Asset prices don't always go up.
Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.
The U.S. Food and Drug Administration has pushed back its decision on Moderna's respiratory syncytial virus (RSV) vaccine by more than two weeks to the end of this month due to some "administrative constraints", the company said on Friday. The FDA's move prolongs the wait for Moderna's second approved product, but the company said it remains on track to be reviewed by a panel of advisers at the U.S. Centers for Disease Control and Prevention (CDC) on June 26 and 27. The CDC panel is expected to vote on recommendations for the vaccine's use and the intended population at the meeting, and success there is necessary for commercial launch.
– Significant advancements in engineering neutralizing antibody (NAb) evasion properties into receptor-targeted capsids, including novel TfR1-binding capsids, demonstrate increased opportunities to treat AAV seropositive patients – Disclosed multiple families of capsids targeting two novel proteins – CA4 and CD59; capsids binding human CA4 cross the blood-brain barrier in humanized mice, while capsids that cross react with human and non-human primate CD59 demonstrate enhanced tropism for the Cen
All amounts in U.S. dollars unless otherwise stated TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2024. “Onex is making progress in its plans to drive growth in shareholder value, and we were pleased to see fundraising start to gain momentum in the quarter,” said Bobby Le Blanc, Chief Executive Officer. “We continue to focus our capital deployment and resource allocation on areas where we have a
Final results from RMCL-002 Phase 2 trial to be presented in the Late Breaking Clinical Trials session at the European Renal Association (ERA) Congress on May 25, 2024. An investor call to provide a perspective on CKD with Dr. Arnold Silva and Dr. Steven Coca and a recap of the RMCL-002 data is planned for May 28, 2024On schedule to resume manufacturing and PROACT 1 Phase 3 trial, commence PROACT 2 Phase 3 trial, and readout interim results from the ongoing REGEN-007 Phase 2 trial in mid-2024Str
FRIENDSWOOD, Texas, May 10, 2024--Castle awarded the "Best Overall Mental Health Solution" in 8th annual MedTech Breakthrough Awards program for IDgenetix® pharmacogenomic (PGx) test
MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced the voting results from its Annual General Meeting of Shareholders held on Thursday May 9, 2024. Voting Results: A total of 12,874,715 common shares were voted at the meeting representing 50.79% of all outstanding shares. Shareholders voted in favour of the elec
The spare parts logistics market size was valued at USD 44.8 Billion in 2023 and is expected to reach a market size of USD 67.4 Billion by 2032 at a CAGR of 4.6%.Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- Growing demand for automotive spare parts drives the industry's growth. Spare Parts Logistics serves as a cornerstone in maintaining the smooth operation and upkeep of essential equipment, machinery, and systems. The increasing focus on asset management and preventive maintenance
GXO Opens New Distribution Hub for Conair GXO opens new distribution hub for Conair in Hagerstown, Maryland. New facility expected to create approximately 700 new jobs over the next 10 years Expansion of GXO’s partnership with Conair creates largest single distribution center in the state of Maryland, serving all major markets in the eastern USA GREENWICH, Conn. and Hagerstown, Md., May 10, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics
DALLAS, May 10, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its first quarter 2024 financial results and provided a corporate update. Recent Highlights: With successful completion of feasibility studies, preparations are underway with collaborator for a potential investigator-initiated trial (IIT) in non-small cell lung cancer with folate receptor α (FRα)-CoStAR
MISSISSAUGA, Ontario, May 10, 2024 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen”) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to report its financial results for the first quarter ended March 31, 2024. “In 2024, we intend to: (1) demonstrate our system at a customer site, (2) further improve our energy efficiency to exceed US DOE 2026 targets to world class efficiency levels, (3) complete pilot scale testing of our large-sc
Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologiesSAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the
NASHVILLE, Tenn., May 10, 2024--i3 Verticals, Inc. (Nasdaq: IIIV) ("i3 Verticals" or the "Company") today reported its financial results for the fiscal second quarter ended March 31, 2024.
Management to host conference call and webcast at 8:30am ETPITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced that it w
NBA Re-Play Uses NBA Archived Footage NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, systems and solutions, today announced the debut of its NBA Re-Play Virtual Sports product exclusively in Greece with long-time partner OPAP. OPAP is the leading gaming company in Greece and one of the most renowned internationally, offering a wide range of games, including numerical lotteries, sports
Yahoo Finance